Zeigler Z, Hasiba U, Lewis J, Vagnucci A, West V, Bezek E
Am J Hematol. 1984 Aug;17(2):209-15. doi: 10.1002/ajh.2830170213.
Platelet function was analyzed in two hypothyroid patients who were taking methyldopa. Results from these two patients are compared to those obtained in seven others with hypothyroidism on no medications. Bleeding times in the two drug patients were 33 and 26 minutes compared to normal values (4.0 to 8.0 minutes) in the other hypothyroid individuals. In addition, platelet aggregation responses to epinephrine, collagen, and ristocetin were abnormal in these two patients; these were normal in the others with hypothyroidism. Repeat studies were done in the first drug patient when she was euthyroid and still receiving methyldopa. Her bleeding time decreased to 11 minutes, platelet retention increased from 31% to 75%, and abnormal aggregation responses corrected to normal. Factor VIII coagulant activity, VIII antigenic activity, VIII ristocetin cofactor activity, and two-dimensional immunoelectrophoresis of VIII antigen were normal. These findings suggest that methyldopa can potentiate the mild platelet function defect seen in patients with hypothyroidism.
对两名正在服用甲基多巴的甲状腺功能减退患者的血小板功能进行了分析。将这两名患者的结果与另外七名未服用药物的甲状腺功能减退患者的结果进行了比较。两名服药患者的出血时间分别为33分钟和26分钟,而其他甲状腺功能减退患者的正常出血时间为(4.0至8.0分钟)。此外,这两名患者对肾上腺素、胶原蛋白和瑞斯托菌素的血小板聚集反应异常;其他甲状腺功能减退患者的这些反应正常。对第一名服药患者在甲状腺功能正常且仍在服用甲基多巴时进行了重复研究。她的出血时间降至11分钟,血小板滞留率从31%升至75%,异常的聚集反应恢复正常。因子VIII凝血活性、VIII抗原活性、VIII瑞斯托菌素辅因子活性以及VIII抗原的二维免疫电泳均正常。这些发现表明,甲基多巴可增强甲状腺功能减退患者中所见的轻度血小板功能缺陷。